Publications
Publications
Show Results For
- All HBS Web
(231)
- Faculty Publications (27)
←
Page 2 of 27
Results
- October 2006 (Revised March 2007)
- Case
Production I.G: Challenging the Status Quo
By: Andrei Hagiu, Tarun Khanna, Felix Oberholzer-Gee, Masako Egawa and Chisato Toyama
In July 2006, Mitsuhisa Ishikawa wondered how he could further enhance the success and visibility of his animation production company headquartered in Tokyo, Production I.G. For the year ended May 2006, Production I.G. had sales of 5,439 million yen ($47.3 million),... View Details
- April 2006
- Case
Finance Leadership in Novartis Consumer Health Businesses
By: Boris Groysberg and Ingrid Vargas
Describes and contrasts the roles and challenges of three high-performing finance heads at Novartis Consumer Health businesses in Australia, Japan, and Venezuela. All three faced tremendous pressures in terms of managing time and limited resources, but the particular... View Details
- December 2005 (Revised October 2006)
- Case
Nest Fresh Eggs (A)
By: Teresa M. Amabile and Victoria Winston
Cyd Szymanski's cage-free egg business was threatened by large caged-hen companies that saw new profit potential in the industry she had helped build. Szymanski had based her company, Nest Fresh Eggs, on a strong personal belief that people deserved healthier... View Details
Keywords: Motivation and Incentives
- June 2005 (Revised September 2008)
- Class Lecture
Strategy: Building and Sustaining Competitive Advantage
By: Bharat N. Anand, Stephen P. Bradley, Pankaj Ghemawat, Tarun Khanna, Cynthia A. Montgomery, Michael E. Porter, Jan W. Rivkin, Michael G. Rukstad, John R. Wells and David B. Yoffie
It's great to have a blockbuster quarter or a revolutionary product or service, but true business excellence demands sustainability. Maintaining your competitive advantage requires a strategy that makes your business unique and carries you forward as the world around... View Details
Keywords: Competitive Advantage
- January 2001
- Case
Abgenix and the XenoMouse
By: Robert J. Dolan
Abgenix has a unique method for generating antibodies useful in treating a number of diseases, including cancer. In early 2000, the company's cancer has performed very well in animal testing and is moving to early stage human testing. Abgenix must decide whether to... View Details
- August 1998 (Revised October 1998)
- Case
Disney's "The Lion King" (A): The $2 Billion Movie
By: Jeffrey F. Rayport, Carin-Isabel Knoop and Cate Reavis
In 1994, just 10 years after its filmed entertainment division lost $33 million, Disney's animated creation "The Lion King" became the second highest grossing film ever. In addition to drawing $740 million in worldwide box office sales, its merchandise sales exceeded... View Details
- May 1998 (Revised May 1999)
- Case
Biopure Corp.
It is early 1998 and Biopure Corp., a small biopharmaceutical firm with no sales revenues in its ten-year history, has just received government approval to release Oxyglobin, a revolutionary new "blood substitute" designed to replace the need for donated animal blood... View Details